Aims-To study the homozygous deletion and methylation status of the 5' CpG island of the p16 and p15 genes (9p2l) in a set of primary advanced head and neck squamous cell carcinomas (SCC) and to test whether inactivation of these genes by these mechanisms contributes to head and neck SCC development. Methods-DNA was extracted from fresh tumours. Homozygous deletion was determined by the polymerase chain reaction (PCR) followed by hybridisation with the corresponding probe, radioactively labelled by the random priiing method. Methylation status ofthe CpG island ofthe 5' region of these genes was assessed by digestion with the appropiate restriction enzymes followed by PCR and subsequent hybridisation with the corresponding probe. The presence of point mutations was determined by PCR-SSCP (single strand conformation polymorphism). Results-The p16 and p15 genes were homozygously deleted in 20% and 10% of the tumours, respectively. No point mutations were found at p16 and p15. The 5' CpG island at the p16 gene was methylated in 20% of the cases. Conclusions-The tumour suppressor gene p16 is inactivated through homozygous deletion or methylation in a significant proportion of cases of head and neck SCC.
Keywords: head and neck squamous cell carcinoma; tumour suppressor genes; homozygous deletion; methylation; CpG island; single strand conformation; polymorphism (p 16, p 15) Head and neck squamous The tumour suppressor gene p1 6/INK4A encodes a protein that belongs to the INK4 family of cdk inhibitors. It binds specifically to cyclin dependent kinase (CDK) 4/6 and prevents it from forming a complex with cyclin DI, thus blocking the entrance into the Gl phase of the cell cycle.'" The cyclin D1/CDK4 complex phosphorylates the retinoblastoma protein (pRB), thus releasing cells from the growth inhibitory effect of unphosphorylated pRB. The lack of p16 or the expression of a mutated form of the p16 protein results in abnormal cell cycling and growth, the features that characterise tumour development." The role of p16 as a tumour suppressor gene in head and neck SCC has recently been demonstrated by transfection of p16 into head and neck SCC cell lines that lacked p16 function, resulting in cell cycle arrest.'2
In accordance with its central role in cell growth inhibition, the p16 gene is frequently mutated in most human cancers, following the two hits model for the inactivation of tumour suppressor genes-one allele is deleted and the other has a point mutation or is deleted. Cell lines and primary tumours from most human cancer types show a high frequency of loss of heterozygosity at chromosome 9p2l, the region where the p16 locus is located. However, they differ in the nature of the second mutation-either a point mutation, resulting in a stop codon, or an amino acid change or a second deletion, resulting in the homozygous deletion of the p16 gene.'3"-" More recently, several authors have established an alternative mechanism for p 16 indicating that inactivation of this ti pressor gene through these two gen4 nisms would be a basic event in the of this type of cancer. 2, cases showing methylation of the p16 5' anism of p16 inactivation. 
